TY - JOUR
T1 - In vitro activities of azithromycin, clarithromycin, erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniae
AU - Welsh, Laura
AU - Gaydos, Charlotte
AU - Quinn, Thomas C.
N1 - Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 1996/1
Y1 - 1996/1
N2 - Thirteen strains of Chlamydia pneumoniae were evaluated for their in vitro susceptibilities to azithromycin, clarithromycin, erythromycin, and tetracycline. The MIC ranges were 0.125 to 0.5 μg/ml for azithromycin, 0.031 to 1.0 μg/ml for clarithromycin, 0.125 to 1.0 μg/ml for erythromycin, and 0.125 to 1.0 μg/ml for tetracycline. The ranges for the minimal lethal concentrations were 0.125 to 0.5 μg/ml for azithromycin, 0.031 to 1.0 μg/ml for clarithromycin, 0.125 to 1.0 μg/ml for erythromycin, and 0.25 to 1.0 μg/ml for tetracycline. Clarithromycin and azithromycin were the most active antibiotics against C. pneumoniae in vitro.
AB - Thirteen strains of Chlamydia pneumoniae were evaluated for their in vitro susceptibilities to azithromycin, clarithromycin, erythromycin, and tetracycline. The MIC ranges were 0.125 to 0.5 μg/ml for azithromycin, 0.031 to 1.0 μg/ml for clarithromycin, 0.125 to 1.0 μg/ml for erythromycin, and 0.125 to 1.0 μg/ml for tetracycline. The ranges for the minimal lethal concentrations were 0.125 to 0.5 μg/ml for azithromycin, 0.031 to 1.0 μg/ml for clarithromycin, 0.125 to 1.0 μg/ml for erythromycin, and 0.25 to 1.0 μg/ml for tetracycline. Clarithromycin and azithromycin were the most active antibiotics against C. pneumoniae in vitro.
UR - http://www.scopus.com/inward/record.url?scp=0030032267&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030032267&partnerID=8YFLogxK
U2 - 10.1128/aac.40.1.212
DO - 10.1128/aac.40.1.212
M3 - Article
C2 - 8787907
AN - SCOPUS:0030032267
VL - 40
SP - 212
EP - 214
JO - Antimicrobial Agents and Chemotherapy
JF - Antimicrobial Agents and Chemotherapy
SN - 0066-4804
IS - 1
ER -